Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
Abstract Background Limited real‐world data exist on treatment patterns and outcomes in patients with metastatic castration‐sensitive prostate cancer (mCSPC). Methods A retrospective cohort study was conducted, using the Veterans Health Administration claims database (April 2013–March 2018). Among 3...
Guardado en:
Autores principales: | Stephen J. Freedland, Rickard Sandin, Janvi Sah, Birol Emir, Qiao Mu, Anna Ratiu, Agnes Hong, Lucile Serfass, Scott T. Tagawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8572d3bbe63c4a15a397dc787e63798d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
por: Ahmed MSU, et al.
Publicado: (2017) -
Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
por: Venturelli M, et al.
Publicado: (2018) -
Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial Peptide
por: Mickael Couty, et al.
Publicado: (2021) -
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
por: Fernando López-Campos, et al.
Publicado: (2021) -
Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
por: Tunn UW, et al.
Publicado: (2013)